MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Simulations Plus Inc

Abrir

SetorSaúde

35.53 -0.75

Visão Geral

Variação de preço das ações

24h

Atual

Mín

34.45

Máximo

36.38

Indicadores-chave

By Trading Economics

Rendimento

2.9M

3.1M

Vendas

3.5M

22M

P/E

Médio do Setor

94.167

57.333

EPS

0.31

Rendimento de Dividendos

0.71

Margem de lucro

13.704

Funcionários

243

EBITDA

2.6M

2.7M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+38.03% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.71%

2.63%

Próximos Ganhos

1 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

189M

682M

Abertura anterior

36.28

Fecho anterior

35.53

Simulations Plus Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de jul. de 2024, 08:59 UTC

Principais Notícias

These Stocks Are Moving the Most Today: Tesla, Paramount, Nvidia, Constellation Brands, and More -- Barrons.com

Comparação entre Pares

Variação de preço

Simulations Plus Inc Previsão

Preço-alvo

By TipRanks

38.03% parte superior

Previsão para 12 meses

Média 48.67 USD  38.03%

Máximo 65 USD

Mínimo 40 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Simulations Plus Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

5

Comprar

1

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.